Detalhe da pesquisa
1.
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
Clin Infect Dis
; 76(3): e995-e1003, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879465
2.
Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience.
J Clin Pharm Ther
; 47(7): 932-939, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255527
3.
Tuberculosis prevention in patients undergoing kidney transplantation: A nurse-led program for screening and treatment.
Transpl Infect Dis
; 23(4): e13603, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745229
4.
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.
PLoS One
; 18(8): e0285917, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647315
5.
Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
PLoS One
; 17(10): e0276387, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269714
6.
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Microbiol Spectr
; 9(3): e0097221, 2021 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756079